Frontiers in Immunology · 20 Nov 2026
Editorial: Precision medicine and targeted therapies in gastrointestinal and genitourinary solid tumors
Rahul Shivahare, Khyati Maulik Kariya
0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
11
References
works it cites, from open citation data
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
No abstract is available for this paper.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
0 shown
No citing papers for this filter.
References (11)
What it cites, from open citation data, with Crossref's record of each.
Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology
295npj Precision Oncology · 2025
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
216Journal of Clinical Oncology · 2023
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
158Nature Reviews Clinical Oncology · 2024
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
138New England Journal of Medicine · 2025
Liquid biopsies across the cancer care continuum
58Nature Medicine · 2025
Advancing AI for multi-omics and clinical data integration in basic and translational cancer research
56Nature Reviews Cancer · 2026
Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649
37Annals of Oncology · 2026
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
17Nature Reviews Clinical Oncology · 2025
Tumor diagnosis recharacterization enabled by comprehensive genomic profiling to guide precision medicine strategy
10npj Precision Oncology · 2025
Usefulness of Comprehensive Genomic Profiling in Clinical Decision-Making in Oncology: A Systematic Review
9Journal of Immunotherapy and Precision Oncology · 2025